Amarantus Requests Rare Pediatric Disease Designation from US FDA for MANF in the Treatment of Retinitis Pigmentosa

SAN FRANCISCO, February 5, 2016 /PRNewswire/ — Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on developing products for Regenerative Medicine, Neurology and Orpha…Read More »

Amarantus Receives Dual Notices of Allowance from European Patent Office for Engineered Skin Substitute (ESS)

SAN FRANCISCO, February 3, 2016 /PRNewswire/ — Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on developing products for Regenerative Medicine, Neurology and Orpha…Read More »

Amarantus Announces Issuance of Chinese Patent Covering Use of MANF for the Treatment of Parkinson's Disease

Patent issuance will provide intellectual property protection in China for protein therapy, gene therapy and cell therapy applications of MANF SAN FRANCISCO, January 29, 2016 /PRNewswire/ — Amarantus…Read More »

Amarantus Announces $1M Investment

SAN FRANCISCO, January 27, 2016 /PRNewswire/ — Amarantus BioScience Holdings, Inc. (OTCQX:AMBS), a biotechnology company developing products in Regenerative Medicine, Neurology and Orphan diseases, t…Read More »

Amarantus Enters Into Letter of Intent to Merge Diagnostics Business Unit Into Avant Diagnostics

SAN FRANCISCO and SCOTTSDALE, Arizona, January 19, 2016 /PRNewswire/ — Amarantus Bioscience Holdings, Inc. (OTCQX:AMBS), a biotechnology company developing products in Regenerative Medicine, Neurolog…Read More »

Forward Looking Statements

Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements." These forward-looking statements generally are identified by the words believes," project," expects," anticipates," estimates," intends," strategy," plan," may," will," would," will be," will continue," will likely result," and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse effect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements.

This Blog is official and sanctioned by Amarantus BioScience | See Disclaimer | See Privacy Policy

Get Amarantus BioScience Blog Post Alerts